These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 32497293)

  • 1. N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease.
    Zampar S; Klafki HW; Sritharen K; Bayer TA; Wiltfang J; Rostagno A; Ghiso J; Miles LA; Wirths O
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):673-685. PubMed ID: 32497293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N‑truncated Abeta in sporadic Alzheimer disease cases and mouse models.
    Bouter Y; Lopez Noguerola JS; Tucholla P; Crespi GA; Parker MW; Wiltfang J; Miles LA; Bayer TA
    Acta Neuropathol; 2015 Nov; 130(5):713-29. PubMed ID: 26467270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.
    Cabrera E; Mathews P; Mezhericher E; Beach TG; Deng J; Neubert TA; Rostagno A; Ghiso J
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):208-225. PubMed ID: 28711595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
    Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-truncated Aβ2-X starting with position two in sporadic Alzheimer's disease cases and two Alzheimer mouse models.
    Savastano A; Klafki H; Haußmann U; Oberstein TJ; Muller P; Wirths O; Wiltfang J; Bayer TA
    J Alzheimers Dis; 2016; 49(1):101-10. PubMed ID: 26529393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex.
    Thal DR; Schultz C; Dehghani F; Yamaguchi H; Braak H; Braak E
    Acta Neuropathol; 2000 Dec; 100(6):608-17. PubMed ID: 11078212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody.
    Antonios G; Saiepour N; Bouter Y; Richard BC; Paetau A; Verkkoniemi-Ahola A; Lannfelt L; Ingelsson M; Kovacs GG; Pillot T; Wirths O; Bayer TA
    Acta Neuropathol Commun; 2013 Sep; 1():56. PubMed ID: 24252153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains.
    Wirths O; Lehnen C; Fricke M; Talucci I; Klafki HW; Morgado B; Lehmann S; Münch C; Liepold T; Wiltfang J; Rostagno A; Ghiso J; Maric HM; Jahn O; Weggen S
    Neuropathol Appl Neurobiol; 2024 Jun; 50(3):e12991. PubMed ID: 38867123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient.
    Roher AE; Maarouf CL; Daugs ID; Kokjohn TA; Hunter JM; Sabbagh MN; Beach TG
    J Alzheimers Dis; 2011; 24(2):315-25. PubMed ID: 21263194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial relationship of AMY protein deposits and different species of Abeta peptides in amyloid plaques of the Alzheimer disease brain.
    Schmidt ML; Saido TC; Lee VM; Trojanowski JQ
    J Neuropathol Exp Neurol; 1999 Dec; 58(12):1227-33. PubMed ID: 10604747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
    Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
    Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
    Cho HS; Hyman BT; Greenberg SM; Rebeck GW
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ.
    Meilandt WJ; Maloney JA; Imperio J; Lalehzadeh G; Earr T; Crowell S; Bainbridge TW; Lu Y; Ernst JA; Fuji RN; Atwal JK
    Alzheimers Res Ther; 2019 Dec; 11(1):97. PubMed ID: 31787113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
    Gkanatsiou E; Sahlin C; Portelius E; Johannesson M; Söderberg L; Fälting J; Basun H; Möller C; Odergren T; Zetterberg H; Blennow K; Lannfelt L; Brinkmalm G
    Neurosci Lett; 2021 May; 754():135894. PubMed ID: 33848613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits.
    Tekirian TL; Saido TC; Markesbery WR; Russell MJ; Wekstein DR; Patel E; Geddes JW
    J Neuropathol Exp Neurol; 1998 Jan; 57(1):76-94. PubMed ID: 9600199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of N-terminally truncated pyroglutamate amyloid-β in cholesterol-enriched diet-fed rabbit and AD brain.
    Perez-Garmendia R; Hernandez-Zimbron LF; Morales MA; Luna-Muñoz J; Mena R; Nava-Catorce M; Acero G; Vasilevko V; Viramontes-Pintos A; Cribbs DH; Gevorkian G
    J Alzheimers Dis; 2014; 39(2):441-55. PubMed ID: 24240639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylated Aβ peptides in human Down syndrome brain and different Alzheimer's-like mouse models.
    Kumar S; Lemere CA; Walter J
    Acta Neuropathol Commun; 2020 Jul; 8(1):118. PubMed ID: 32727580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.